{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:07:27Z","timestamp":1791572847670,"version":"4.3.4"},"reference-count":268,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ethos Resident Training Grant"},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["1F31HL186643-01"],"award-info":[{"award-number":["1F31HL186643-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"award":["1F31HL186643-01"],"award-info":[{"award-number":["1F31HL186643-01"]}],"id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Comparative oncology uses naturally occurring cancers in companion animals to study tumor biology and therapeutic responses relevant to human cancer. Spontaneous feline tumors are increasingly recognized as useful comparative models because they arise in immunocompetent hosts, develop under shared environmental exposures, and can reproduce selected clinical, histopathologic, molecular, and therapeutic features of human malignancies. Methods: This review compares feline oral squamous cell carcinoma (FOSCC) with human head and neck squamous cell carcinoma (HNSCC), and feline mammary carcinoma (FMC) with human breast cancer, emphasizing shared pathologic, molecular, tumor microenvironment, and therapeutic features. Results: Recent immunohistochemical, genomic, transcriptomic, and biomarker studies have identified shared features between feline and human cancers. FOSCC resembles human HNSCC through aggressive local invasion, histologic features, therapeutic resistance, and recurrent alterations of TP53, MYC, and PTEN. FMC shows strong overlap with aggressive human triple-negative breast cancer, including reduced hormone receptor expression, recurrent TP53, PIK3CA, and CXCL12\/CXCR4 signaling alterations, and tumor microenvironment features involving immune-checkpoint, inflammatory, and angiogenic pathways. FOSCC clinical trials and emerging clinical investigations into FMC treatments further support the use of cats for translational therapy evaluation. Conclusions: FOSCC and FMC are promising comparative oncology models for human HNSCC and aggressive breast cancer, respectively. Future multicenter studies incorporating standardized tumor classification and grading, predefined stratification criteria, and clinically meaningful endpoints will be essential to strengthen their translational value.<\/jats:p>","DOI":"10.3390\/cancers18132136","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:41:01Z","timestamp":1782902461000},"page":"2136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Naturally Occurring Feline Cancers in Comparative Oncology: Translational Insights from Oral Squamous Cell Carcinoma and Mammary Carcinoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-8107","authenticated-orcid":false,"given":"Yinghua","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"},{"name":"Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA"},{"name":"Wisconsin Blood Cancer Research Institute, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian Elizabeth","family":"Yant","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8308-8495","authenticated-orcid":false,"given":"Xuan","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"},{"name":"Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA"},{"name":"Wisconsin Blood Cancer Research Institute, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tu, A.Y., Springer, C.M., and Albright, J.D. (2024). Evaluation of Characteristics Associated with Self-Identified Cat or Dog Preference in Pet Owners and Correlation of Preference with Pet Interactions and Care: An Exploratory Study. Animals, 14.","DOI":"10.3390\/ani14172534"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00046339","article-title":"Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment","volume":"9","author":"MacEwen","year":"1990","journal-title":"Cancer Metastasis Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/07357900009012210","article-title":"Spontaneously occurring tumors of companion animals as models for human cancer","volume":"18","author":"Vail","year":"2000","journal-title":"Cancer Investig."},{"key":"ref_4","first-page":"111","article-title":"Cats, Cancer and Comparative Oncology","volume":"2","author":"Cannon","year":"2015","journal-title":"Vet. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","article-title":"Comparative oncology: Overcoming human cancer through companion animal studies","volume":"55","author":"Oh","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.pmbts.2021.12.003","article-title":"Canine models of human cancer: Bridging the gap to improve precision medicine","volume":"189","author":"Nance","year":"2022","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/labinvest.3700695","article-title":"\u2018One medicine\u2014One pathology\u2019: Are veterinary and human pathology prepared?","volume":"88","author":"Cardiff","year":"2008","journal-title":"Lab. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/ETLS20200353","article-title":"The One Medicine concept: Its emergence from history as a systematic approach to re-integrate human and veterinary medicine","volume":"5","author":"King","year":"2021","journal-title":"Emerg. Top. Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"De Haes, C., de Rooster, H., Demeyere, K., Van de Vijver, K., De Cock, H., Meyer, E., and Steenbrugge, J. (2026). Grade III canine and feline mammary carcinomas are associated with an immunosuppressed, vascularized and proliferative microenvironment. BMC Vet. Res., 22.","DOI":"10.1186\/s12917-026-05393-z"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rodrigues-Jesus, J., Canadas-Sousa, A., Vilhena, H., and Dias-Pereira, P. (2025). Inside the Tumor: Decoding the Feline Mammary Tumor Microenvironment and Its Prognostic Value\u2014A Review. Vet. Sci., 12.","DOI":"10.3390\/vetsci12100959"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Alkayyal, A.A. (2025). Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology. Front. Mol. Biosci., 12.","DOI":"10.3389\/fmolb.2025.1615393"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/vco.70054","article-title":"Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma","volume":"24","author":"Chu","year":"2026","journal-title":"Vet. Comp. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/vco.12800","article-title":"Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas","volume":"20","author":"Sommerville","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"45016","DOI":"10.1038\/s41598-025-28751-7","article-title":"Novel organoid-based exploration reveals the role of LMTK3\/FADS2 signaling in metastatic breast cancer progression in felines and humans","volume":"15","author":"Yamamoto","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Alshammari, A.H., Oshiro, T., Ungkulpasvich, U., Yamaguchi, J., Morishita, M., Khdair, S.A., Hatakeyama, H., Hirotsu, T., and di Luccio, E. (2025). Advancing Veterinary Oncology: Next-Generation Diagnostics for Early Cancer Detection and Clinical Implementation. Animals, 15.","DOI":"10.3390\/ani15030389"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.ady6651","article-title":"The oncogenome of the domestic cat","volume":"391","author":"Francis","year":"2026","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ahn, S., and Yun, J.H. (2026). Comparative Cancer Genetics and Veterinary Therapeutics in Dogs and Cats: A Species-Aware Framework for Comparative Oncology. Life, 16.","DOI":"10.3390\/life16030430"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"dmm049044","DOI":"10.1242\/dmm.049044","article-title":"Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma","volume":"14","author":"Wong","year":"2021","journal-title":"Dis. Models Mech."},{"key":"ref_19","unstructured":"(2020). The ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature, 578, 82\u201393."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/1078-0432.CCR-21-4316","article-title":"Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer","volume":"28","author":"Deneka","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41379-020-00716-3","article-title":"TP53 mutations and CDKN2A mutations\/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas","volume":"34","author":"Brown","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","article-title":"TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines","volume":"6","author":"Shahbandi","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41598-023-31759-6","article-title":"Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome","volume":"13","author":"Vidotto","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Giuliano, A., Swift, R., Arthurs, C., Marote, G., Abramo, F., McKay, J., Thomson, C., Beltran, M., Millar, M., and Priestnall, S. (2016). Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma. PLoS ONE, 11, Correction in PLoS ONE\u00a02016, 11, e0163838. https:\/\/doi.org\/10.1371\/journal.pone.0163838.","DOI":"10.1371\/journal.pone.0163838"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Groll, T., Schopf, F., Denk, D., Mogler, C., Schwittlick, U., Aupperle-Lellbach, H., Sarker, S.R.J., Pfarr, N., Weichert, W., and Matiasek, K. (2021). Bridging the Species Gap: Morphological and Molecular Comparison of Feline and Human Intestinal Carcinomas. Cancers, 13.","DOI":"10.3390\/cancers13235941"},{"key":"ref_27","first-page":"2055116917691069","article-title":"Metastatic pulmonary carcinomas in cats (\u2018feline lung-digit syndrome\u2019): Further variations on a theme","volume":"3","author":"Thrift","year":"2017","journal-title":"JFMS Open Rep."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wiese, D.A., Thaiwong, T., Yuzbasiyan-Gurkan, V., and Kiupel, M. (2013). Feline mammary basal-like adenocarcinomas: A potential model for human triple-negative breast cancer (TNBC) with basal-like subtype. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-403"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gameiro, A., Urbano, A.C., and Ferreira, F. (2021). Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.625147"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"502197","DOI":"10.1155\/2013\/502197","article-title":"A naturally occurring feline model of head and neck squamous cell carcinoma","volume":"2013","author":"Wypij","year":"2013","journal-title":"Pathol. Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"108491","DOI":"10.1016\/j.vetmic.2019.108491","article-title":"A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors","volume":"240","author":"Chu","year":"2020","journal-title":"Vet. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/089875641503200104","article-title":"Feline Oral Squamous Cell Carcinoma: Clinical Manifestations and Literature Review","volume":"32","author":"Bilgic","year":"2015","journal-title":"J. Vet. Dent."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tutu, P., Daraban Bocaneti, F., Altamura, G., Dascalu, M.A., Horodincu, L., Soreanu, O.D., Tanase, O.I., Borzacchiello, G., and Mares, M. (2025). Feline oral squamous cell carcinoma: Recent advances and future perspectives. Front. Vet. Sci., 12.","DOI":"10.3389\/fvets.2025.1663990"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rodney, A.R., Skidmore, Z.L., Grenier, J.K., Griffith, O.L., Miller, A.D., Chu, S., Ahmed, F., Bryan, J.N., Peralta, S., and Warren, W.C. (2023). Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1079019"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sequeira, I., Pires, M.D.A., Leitao, J., Henriques, J., Viegas, C., and Requicha, J. (2022). Feline Oral Squamous Cell Carcinoma: A Critical Review of Etiologic Factors. Vet. Sci., 9.","DOI":"10.3390\/vetsci9100558"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetimm.2018.06.011","article-title":"Investigation of immune cell markers in feline oral squamous cell carcinoma","volume":"202","author":"Sparger","year":"2018","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0300985810384414","article-title":"Bone-invasive oral squamous cell carcinoma in cats: Pathology and expression of parathyroid hormone-related protein","volume":"48","author":"Martin","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1098612X13502975","article-title":"Prevalence of regional and distant metastasis in cats with advanced oral squamous cell carcinoma: 49 cases (2005\u20132011)","volume":"16","author":"Krick","year":"2014","journal-title":"J. Feline Med. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1476-5829.2010.00239.x","article-title":"Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC)","volume":"9","author":"Bergkvist","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1098612X251314343","DOI":"10.1177\/1098612X251314343","article-title":"Treatment of feline oral squamous cell carcinoma with accelerated radiation and carboplatin with and without follow-up toceranib phosphate","volume":"27","author":"Schlueter","year":"2025","journal-title":"J. Feline Med. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.ccell.2025.07.015","article-title":"Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer","volume":"43","author":"Grandis","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1748-5827.2007.00393.x","article-title":"Survival of 54 cats with oral squamous cell carcinoma in United Kingdom general practice","volume":"48","author":"Hayes","year":"2007","journal-title":"J. Small Anim. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1038\/s41598-019-48229-7","article-title":"Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy","volume":"9","author":"Veeramachaneni","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Powell, S.F., Vu, L., Spanos, W.C., and Pyeon, D. (2021). The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications. Cancers, 13.","DOI":"10.3390\/cancers13205206"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-24-0281","article-title":"Advanced Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies","volume":"23","author":"Park","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.7150\/ijbs.33329","article-title":"Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients","volume":"15","author":"Qian","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mittal, K., Choi, D.H., Wei, G., Kaur, J., Klimov, S., Arora, K., Griffith, C.C., Kumar, M., Imhansi-Jacob, P., and Melton, B.D. (2020). Hypoxia-Induced Centrosome Amplification Underlies Aggressive Disease Course in HPV-Negative Oropharyngeal Squamous Cell Carcinomas. Cancers, 12.","DOI":"10.3390\/cancers12020517"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tvjl.2019.04.007","article-title":"Increased p16(CDKN2A), but not p53, immunostaining is predictive of longer survival time in cats with oral squamous cell carcinomas","volume":"248","author":"Munday","year":"2019","journal-title":"Vet. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Altamura, G., and Borzacchiello, G. (2023). Feline oral squamous cell carcinoma and Felis catus papillomavirus: Is it time to walk the path of human oncology?. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1148673"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.rvsc.2010.06.014","article-title":"Evaluation of feline oral squamous cell carcinomas for p16CDKN2A protein immunoreactivity and the presence of papillomaviral DNA","volume":"90","author":"Munday","year":"2011","journal-title":"Res. Vet. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1292\/jvms.22-0060","article-title":"Investigation of multiple Felis catus papillomavirus types (-1\/-2\/-3\/-4\/-5\/-6) DNAs in feline oral squamous cell carcinoma: A multicentric study","volume":"84","author":"Altamura","year":"2022","journal-title":"J. Vet. Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1292\/jvms.21-0153","article-title":"Comparison of prevalence of Felis catus papillomavirus type 2 in squamous cell carcinomas in cats between Taiwan and Japan","volume":"83","author":"Chang","year":"2021","journal-title":"J. Vet. Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/vco.12569","article-title":"Detection of Felis catus papillomavirus type-2 DNA and viral gene expression suggest active infection in feline oral squamous cell carcinoma","volume":"18","author":"Altamura","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2130583","DOI":"10.1080\/2162402X.2022.2130583","article-title":"Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.oooo.2020.05.001","article-title":"Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2\u2032-deoxycytidine","volume":"130","author":"Borgato","year":"2020","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hed.25932","article-title":"Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy","volume":"41","author":"Hsieh","year":"2019","journal-title":"Head Neck"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tvjl.2015.11.006","article-title":"Animal models of head and neck squamous cell carcinoma","volume":"210","author":"Supsavhad","year":"2016","journal-title":"Vet. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"200245","DOI":"10.1016\/j.tvr.2022.200245","article-title":"HPV and head and neck cancers: Towards early diagnosis and prevention","volume":"14","author":"Galati","year":"2022","journal-title":"Tumour Virus Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/s41388-021-02137-1","article-title":"A dysbiotic microbiome promotes head and neck squamous cell carcinoma","volume":"41","author":"Frank","year":"2022","journal-title":"Oncogene"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Miranda-Galvis, M., Loveless, R., Kowalski, L.P., and Teng, Y. (2021). Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression. Cells, 10.","DOI":"10.3390\/cells10020389"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1939-1676.2003.tb02478.x","article-title":"Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats","volume":"17","author":"Bertone","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1354\/vp.41-3-209","article-title":"p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma","volume":"41","author":"Snyder","year":"2004","journal-title":"Vet. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.pathol.4.110807.092158","article-title":"Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment","volume":"4","author":"Pai","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"ref_66","first-page":"186","article-title":"Infrequent Histopathologic Subtypes of Oral Squamous Cell Carcinoma: A Case Series with Emphasis on Histopathologic Characteristics","volume":"26","author":"Lotfi","year":"2025","journal-title":"J. Dent."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"102149","DOI":"10.1016\/j.jormas.2024.102149","article-title":"Prognostic implications across histological subtypes of head and neck squamous cell carcinoma: An update","volume":"126","author":"Goncalves","year":"2025","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_68","first-page":"95","article-title":"Histopathological Investigation of Feline Oral Squamous Cell Carcinoma and the Possible Role of Papillomavirus Infection","volume":"42","author":"Almilli","year":"2022","journal-title":"Pak. Vet. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/0300985816629713","article-title":"High Numbers of Stromal Cancer-Associated Fibroblasts Are Associated With a Shorter Survival Time in Cats With Oral Squamous Cell Carcinoma","volume":"53","author":"Klobukowska","year":"2016","journal-title":"Vet. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-14-0205","article-title":"A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease","volume":"20","author":"Onken","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Miniuk, M., Reszec-Gielazyn, J., Bortnik, P., Borsukiewicz, A., and Mroczek, A. (2024). Novel Predictive Biomarkers in the Head and Neck Squamous Cell Carcinoma (HNSCC). J. Clin. Med., 13.","DOI":"10.3390\/jcm13195876"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2015). Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 517, 576\u2013582.","DOI":"10.1038\/nature14129"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Mahmoud, A.A., Raih, M.F., Sage, E.E., Ali, Q.M., Suliman, O.H., Ibrahim, S.A.E., Mohamed, O., Abdelrazeg, S., and Mohamed, S.B. (2025). The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0307859"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Gonzalez-Gonzalez, R., Ortiz-Sarabia, G., Molina-Frechero, N., Salas-Pacheco, J.M., Salas-Pacheco, S.M., Lavalle-Carrasco, J., Lopez-Verdin, S., Tremillo-Maldonado, O., and Bologna-Molina, R. (2021). Epithelial-Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review. Cancers, 13.","DOI":"10.3390\/cancers13123027"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ai, J., Tan, Y., Liu, B., Song, Y., Wang, Y., Xia, X., and Fu, Q. (2023). Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma. Front. Genet., 14.","DOI":"10.3389\/fgene.2023.1113137"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Pawlicka, M., Gumbarewicz, E., Blaszczak, E., and Stepulak, A. (2024). Transcription Factors and Markers Related to Epithelial-Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers. Cancers, 16.","DOI":"10.3390\/cancers16071354"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"de Morais, E.F., de Oliveira, L.Q.R., Marques, C.E., Teo, F.H., Rocha, G.V., Rodini, C.O., Gurgel, C.A., Salo, T., Graner, E., and Coletta, R.D. (2025). Generation and Characterization of Cisplatin-Resistant Oral Squamous Cell Carcinoma Cells Displaying an Epithelial-Mesenchymal Transition Signature. Cells, 14.","DOI":"10.3390\/cells14171311"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/0300985819859873","article-title":"Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma","volume":"56","author":"Harris","year":"2019","journal-title":"Vet. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Nasry, W.H.S., Wang, H., Jones, K., Dirksen, W.P., Rosol, T.J., Rodriguez-Lecompte, J.C., and Martin, C.K. (2018). CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma. Vet. Sci., 5.","DOI":"10.3390\/vetsci5030072"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Brown, M.E., Bear, M.D., Rosol, T.J., Premanandan, C., Kisseberth, W.C., and London, C.A. (2015). Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma. BMC Vet. Res., 11.","DOI":"10.1186\/s12917-015-0505-7"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3724\/abbs.2024166","article-title":"pSTAT3 transactivates EGFR in maintaining EGFR protein homeostasis and EGFR-TKI resistance","volume":"57","author":"Ao","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13046-022-02376-4","article-title":"Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2\/STAT3\/Sox4\/NLRP3 signaling pathway","volume":"41","author":"Xiao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41698-025-01020-6","article-title":"Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer","volume":"9","author":"Paschold","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hed.21468","article-title":"Prognostic significance of nuclear pSTAT3 in oral cancer","volume":"33","author":"Macha","year":"2011","journal-title":"Head Neck"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"15913","DOI":"10.1007\/s13277-016-5439-6","article-title":"Transcriptomic characterization of differential gene expression in oral squamous cell carcinoma: A meta-analysis of publicly available microarray data sets","volume":"37","author":"Sun","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_87","first-page":"2948","article-title":"Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine\/paracrine stimulation of the interleukin 6\/gp130 cytokine system","volume":"63","author":"Sriuranpong","year":"2003","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1476-5810.2006.00091.x","article-title":"Epidermal growth factor receptor expression in feline oral squamous cell carcinomas","volume":"4","author":"Looper","year":"2006","journal-title":"Vet. Comp. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2014.04.027","article-title":"Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance","volume":"436","author":"Aggarwal","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00432-009-0648-7","article-title":"A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment","volume":"135","author":"Marcu","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cardiores.2005.09.019","article-title":"Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells","volume":"69","author":"Wu","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.neo.7900127","article-title":"Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis","volume":"3","author":"Gallo","year":"2001","journal-title":"Neoplasia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jobcr.2023.07.002","article-title":"Prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression and its association with genes regulating the VEGF signaling pathway in head and neck squamous cell carcinoma","volume":"13","author":"Kamal","year":"2023","journal-title":"J. Oral Biol. Craniofac. Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Guo, Z., Li, K., Liu, P., Zhang, X., Lv, J., Zeng, X., and Zhang, P. (2023). Targeted therapy for head and neck squamous cell carcinoma microenvironment. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1257898"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Nasry, W.H.S., Rodriguez-Lecompte, J.C., and Martin, C.K. (2018). Role of COX-2\/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. Cancers, 10.","DOI":"10.3390\/cancers10100348"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/hupa.2002.125376","article-title":"Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma","volume":"33","author":"Gallo","year":"2002","journal-title":"Hum. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1354\/vp.40-5-496","article-title":"An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms","volume":"40","author":"Beam","year":"2003","journal-title":"Vet. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.plefa.2007.01.006","article-title":"Study of feline oral squamous cell carcinoma: Potential target for cyclooxygenase inhibitor treatment","volume":"76","author":"DiBernardi","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1556\/004.2020.00005","article-title":"Expression levels of angiogenic growth factors in feline squamous cell carcinoma","volume":"68","author":"Kabak","year":"2020","journal-title":"Acta Vet. Hung."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcpa.2016.02.005","article-title":"Correlation Between Cyclo-oxygenase-2 and Vascular Endothelial Growth Factor Expression in Canine and Feline Squamous Cell Carcinomas","volume":"154","author":"Millanta","year":"2016","journal-title":"J. Comp. Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/sj.onc.1203703","article-title":"Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays","volume":"19","author":"Leethanakul","year":"2000","journal-title":"Oncogene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/154405910408300411","article-title":"Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity","volume":"83","author":"Uraguchi","year":"2004","journal-title":"J. Dent. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0022034518771923","article-title":"Emerging Insights into Wnt\/beta-catenin Signaling in Head and Neck Cancer","volume":"97","author":"Abalkhail","year":"2018","journal-title":"J. Dent. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gde.2006.12.007","article-title":"The many ways of Wnt in cancer","volume":"17","author":"Polakis","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Hsu, P.C., Huang, J.H., Tsai, C.C., Lin, Y.H., and Kuo, C.Y. (2025). Early Molecular Diagnosis and Comprehensive Treatment of Oral Cancer. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47060452"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Li, C., Fang, Y., Xu, S., Zhao, J., Dong, D., and Li, S. (2024). Nanomedicine in HNSCC therapy-a challenge to conventional therapy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1434994"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Yang, C., Pang, X., Teng, S., Wilson, S., Gu, X., and Xie, G. (2025). MYC Overexpression Enhances Sensitivity to MEK Inhibition in Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020588"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41698-024-00606-w","article-title":"Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer","volume":"8","author":"Cyberski","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"45047","DOI":"10.1038\/s41598-025-31764-x","article-title":"HPV16-miR-H1 promotes proliferation, migration, and glycolysis in head and neck squamous cell carcinoma cells via the PTEN\/AKT pathway","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41419-020-2627-5","article-title":"The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/1535-7163.MCT-19-1036","article-title":"Pathway-Specific Genome Editing of PI3K\/mTOR Tumor Suppressor Genes Reveals that PTEN Loss Contributes to Cetuximab Resistance in Head and Neck Cancer","volume":"19","author":"Izumi","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1593\/neo.121024","article-title":"PTEN deficiency contributes to the development and progression of head and neck cancer","volume":"15","author":"Squarize","year":"2013","journal-title":"Neoplasia"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/RPS.RPS_209_23","article-title":"A comprehensive bioinformatics analysis of fatty acid metabolism-associated genes in the diagnosis and prognosis of head and neck squamous cell carcinoma","volume":"20","author":"Fesharaki","year":"2025","journal-title":"Res. Pharm. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1010428320938494","DOI":"10.1177\/1010428320938494","article-title":"FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients","volume":"42","author":"Costa","year":"2020","journal-title":"Tumour Biol."},{"key":"ref_115","first-page":"3137","article-title":"Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma","volume":"8","author":"Reichert","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Xue, L., Tang, W., Zhou, J., Xue, J., Li, Q., Ge, X., Lin, F., Zhao, W., and Guo, Y. (2023). Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1276009"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/CMAR.S187780","article-title":"Novel genetic alterations and their impact on target therapy response in head and neck squamous cell carcinoma","volume":"11","author":"Jiang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1159\/000494473","article-title":"The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis","volume":"50","author":"Zhou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Supsavhad, W., Dirksen, W.P., Hildreth, B.E., and Rosol, T.J. (2016). p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma. Vet. Sci., 3.","DOI":"10.3390\/vetsci3030018"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Chen, Y.H., Chien, C.Y., Wang, Y.M., and Li, S.H. (2022). Serum Levels of Stromal Cell-Derived Factor-1alpha and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040803"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40425-016-0138-9","article-title":"Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients","volume":"4","author":"Sridharan","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/ijo_00000193","article-title":"VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker","volume":"34","author":"Sugiura","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2460\/javma.236.3.319","article-title":"Computed tomographic features of oral squamous cell carcinoma in cats: 18 cases (2002\u20132008)","volume":"236","author":"Gendler","year":"2010","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Strohmayer, C., Klang, A., and Kneissl, S. (2020). Computed Tomographic and Histopathological Characteristics of 13 Equine and 10 Feline Oral and Sinonasal Squamous Cell Carcinomas. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.591437"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Szturz, P., Wouters, K., Kiyota, N., Tahara, M., Prabhash, K., Noronha, V., Adelstein, D., Van Gestel, D., and Vermorken, J.B. (2019). Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00086"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13014-021-01966-4","article-title":"Three weekly versus weekly concurrent cisplatin: Safety propensity score analysis on 166 head and neck cancer patients","volume":"16","author":"Buglione","year":"2021","journal-title":"Radiat. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"de Maar, J.S., Zandvliet, M., Veraa, S., Tobon Restrepo, M., Moonen, C.T.W., and Deckers, R. (2023). Ultrasound and Microbubbles Mediated Bleomycin Delivery in Feline Oral Squamous Cell Carcinoma\u2014An In Vivo Veterinary Study. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041166"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.addr.2021.02.015","article-title":"Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery","volume":"172","author":"Deprez","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ultrasmedbio.2019.12.008","article-title":"Three Decades of Ultrasound Contrast Agents: A Review of the Past, Present and Future Improvements","volume":"46","author":"Frinking","year":"2020","journal-title":"Ultrasound Med. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/17425247.2018.1547279","article-title":"Sonopermeation to improve drug delivery to tumors: From fundamental understanding to clinical translation","volume":"15","author":"Snipstad","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00261-018-1516-1","article-title":"Imaging with ultrasound contrast agents: Current status and future","volume":"43","author":"Chong","year":"2018","journal-title":"Abdom. Radiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-007-0531-2","article-title":"Regulation of ornithine decarboxylase during oncogenic transformation: Mechanisms and therapeutic potential","volume":"33","author":"Shantz","year":"2007","journal-title":"Amino Acids"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd2243","article-title":"Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases","volume":"6","author":"Casero","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_135","first-page":"3878","article-title":"Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N\u2032-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme","volume":"6","author":"Levin","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_136","first-page":"3438","article-title":"Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients","volume":"5","author":"Demers","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/ijc.21621","article-title":"Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma","volume":"118","author":"Chen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1476-5829.2011.00264.x","article-title":"Phase I\/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma","volume":"9","author":"Skorupski","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Liu, T.A., Stewart, T.M., and Casero, R. (2024). The Synergistic Benefit of Combination Strategies Targeting Tumor Cell Polyamine Homeostasis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158173"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/089875641303000301","article-title":"Polyamine inhibitors for treatment of feline oral squamous cell carcinoma: A proof-of-concept study","volume":"30","author":"Lewis","year":"2013","journal-title":"J. Vet. Dent."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Pinello, K., Pires, I., Castro, A.F., Carvalho, P.T., Santos, A., de Matos, A., Queiroga, F., and Niza-Ribeiro, J. (2022). Vet-OncoNet: Developing a Network of Veterinary Oncology and Reporting a Pioneering Portuguese Experience. Vet. Sci., 9.","DOI":"10.3390\/vetsci9020072"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Rodrigues-Jesus, J., Vilhena, H., Canadas-Sousa, A., and Dias-Pereira, P. (2025). Feline Mammary Tumors: A Comprehensive Review of Histological Classification Schemes, Grading Systems, and Prognostic Factors. Vet. Sci., 12.","DOI":"10.3390\/vetsci12080736"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jfms.2010.08.008","article-title":"Morbidity of insured Swedish cats during 1999-2006 by age, breed, sex, and diagnosis","volume":"12","author":"Egenvall","year":"2010","journal-title":"J. Feline Med. Surg."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"105789","DOI":"10.1016\/j.rvsc.2025.105789","article-title":"Lymph node status of felines affected by mammary gland neoplasms: A look beyond the presence or absence of metastasis","volume":"193","author":"Souza","year":"2025","journal-title":"Res. Vet. Sci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1098612X20964416","article-title":"Metastatic feline mammary cancer: Prognostic factors, outcome and comparison of different treatment modalities\u2014A retrospective multicentre study","volume":"23","author":"Petrucci","year":"2021","journal-title":"J. Feline Med. Surg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.semcdb.2020.09.010","article-title":"Comparative mammary gland postnatal development and tumourigenesis in the sheep, cow, cat and rabbit: Exploring the menagerie","volume":"114","author":"Hughes","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1439-0264.2009.00942.x","article-title":"The lymph drainage pattern of the mammary glands in the cat: A lymphographic and computerized tomography lymphographic study","volume":"38","author":"Papadopoulou","year":"2009","journal-title":"Anat. Histol. Embryol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jmor.10403","article-title":"Lymph drainage of the mammary glands in female cats","volume":"267","author":"Raharison","year":"2006","journal-title":"J. Morphol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1748-5827.1966.tb04394.x","article-title":"The anatomy of the mammary gland of the dog and cat","volume":"7","author":"Silver","year":"1966","journal-title":"J. Small Anim. Pract."},{"key":"ref_150","first-page":"e1851","article-title":"Current understanding and distinct features of multifocal and multicentric breast cancers","volume":"6","author":"Avera","year":"2023","journal-title":"Cancer Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1098612X13483237","article-title":"Mammary tumours in the cat: Size matters, so early intervention saves lives","volume":"15","author":"Morris","year":"2013","journal-title":"J. Feline Med. Surg."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/vco.12987","article-title":"Distribution of Inflammatory Infiltrate in Feline Mammary Lesions: Relationship With Clinicopathological Features","volume":"22","author":"Oliveira","year":"2024","journal-title":"Vet. Comp. Oncol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.breast.2016.02.016","article-title":"Molecular based subtyping of feline mammary carcinomas and clinicopathological characterization","volume":"27","author":"Soares","year":"2016","journal-title":"Breast"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Kuhn, E., Gambini, D., Despini, L., Asnaghi, D., Runza, L., and Ferrero, S. (2023). Updates on Lymphovascular Invasion in Breast Cancer. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030968"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00428-021-03141-2","article-title":"Grading of invasive breast carcinoma: The way forward","volume":"480","author":"Ellis","year":"2022","journal-title":"Virchows Arch."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41598-020-57942-7","article-title":"Analysis of Copy-Number Variations and Feline Mammary Carcinoma Survival","volume":"10","author":"Beck","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Adega, F., Borges, A., and Chaves, R. (2016). Cat Mammary Tumors: Genetic Models for the Human Counterpart. Vet. Sci., 3.","DOI":"10.3390\/vetsci3030017"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Maniscalco, L., Millan, Y., Iussich, S., Denina, M., Sanchez-Cespedes, R., Gattino, F., Biolatti, B., Sasaki, N., Nakagawa, T., and Di Renzo, M.F. (2013). Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas. BMC Vet. Res., 9.","DOI":"10.1186\/1746-6148-9-80"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Caliari, D., Zappulli, V., Rasotto, R., Cardazzo, B., Frassineti, F., Goldschmidt, M.H., and Castagnaro, M. (2014). Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer. BMC Vet. Res., 10.","DOI":"10.1186\/s12917-014-0185-8"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Ludwig, L., Dobromylskyj, M., Wood, G.A., and van der Weyden, L. (2022). Feline Oncogenomics: What Do We Know about the Genetics of Cancer in Domestic Cats?. Vet. Sci., 9.","DOI":"10.3390\/vetsci9100547"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Lebok, P., Kopperschmidt, V., Kluth, M., Hube-Magg, C., Ozden, C., B, T., Hussein, K., Mittenzwei, A., Lebeau, A., and Witzel, I. (2015). Partial PTEN deletion is linked to poor prognosis in breast cancer. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1770-3"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: Divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/vr.108.22.476","article-title":"Epidemiological features of feline mammary carcinoma","volume":"108","author":"Hayes","year":"1981","journal-title":"Vet. Rec."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1939-1676.2005.tb02727.x","article-title":"Association between ovarihysterectomy and feline mammary carcinoma","volume":"19","author":"Overley","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/bjc.2014.64","article-title":"Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: Results from the Breakthrough Generations Study","volume":"110","author":"Schoemaker","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cam4.1427","article-title":"Risk factors for breast cancer in a cohort of mammographic screening program: A nested case-control study within the FRiCaM study","volume":"7","author":"Bravi","year":"2018","journal-title":"Cancer Med."},{"key":"ref_167","first-page":"e20250240","article-title":"Evaluation of breast cancer symptoms and risk factors in women: The case of Turkiye","volume":"59","author":"Ahi","year":"2025","journal-title":"Rev. Esc. Enferm. USP"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Pinello, K., Pires, I., Castro, A.F., Carvalho, P.T., Santos, A., de Matos, A., Queiroga, F., Canadas-Sousa, A., Dias-Pereira, P., and Catarino, J. (2022). Cross Species Analysis and Comparison of Tumors in Dogs and Cats, by Age, Sex, Topography and Main Morphologies. Data from Vet-OncoNet. Vet. Sci., 9.","DOI":"10.3390\/vetsci9040167"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/1098612X20905035","article-title":"Tumours in European Shorthair cats: A retrospective study of 680 cases","volume":"22","author":"Manuali","year":"2020","journal-title":"J. Feline Med. Surg."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Marshall, T., Chen, J., and Viloria-Petit, A.M. (2023). Adipocyte-Derived Adipokines and Other Obesity-Associated Molecules in Feline Mammary Cancer. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082309"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jfms.2009.08.004","article-title":"Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990\u20132006)","volume":"12","author":"Jacobs","year":"2010","journal-title":"J. Feline Med. Surg."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1939-1676.2005.tb02658.x","article-title":"Clinical characteristics of mammary carcinoma in male cats","volume":"19","author":"Skorupski","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Giugliano, R., Dell\u2019Anno, F., De Paolis, L., Crescio, M.I., Ciccotelli, V., Vivaldi, B., and Razzuoli, E. (2024). Mammary gland, skin and soft tissue tumors in pet cats: Findings of the feline tumors collected from 2002 to 2022. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1320696"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jsap.13598","article-title":"Epidemiology and risk factors for mammary tumours in female cats","volume":"64","author":"Stell","year":"2023","journal-title":"J. Small Anim. Pract."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0300985814528221","article-title":"Prognostic evaluation of feline mammary carcinomas: A review of the literature","volume":"52","author":"Zappulli","year":"2015","journal-title":"Vet. Pathol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jfms.2006.04.004","article-title":"Clinical, cytological and histopathological evaluation of mammary masses in cats from Rio de Janeiro, Brazil","volume":"8","author":"Amorim","year":"2006","journal-title":"J. Feline Med. Surg."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1292\/jvms.58.723","article-title":"Prognosis of malignant mammary tumor in 53 cats","volume":"58","author":"Ito","year":"1996","journal-title":"J. Vet. Med. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Souza, F.R., Moreira, I.S., Dariva, A.A., Nakagaki, K.Y.R., Abreu, C.C., Balabram, D., and Cassali, G.D. (2024). Epidemiologic and Clinicopathological Characterization of Feline Mammary Lesions. Vet. Sci., 11.","DOI":"10.3390\/vetsci11110549"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/bcr628","article-title":"Oestrogen exposure and breast cancer risk","volume":"5","author":"Travis","year":"2003","journal-title":"Breast Cancer Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr921","article-title":"Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones","volume":"6","author":"Hankinson","year":"2004","journal-title":"Breast Cancer Res."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Mahasa, P.S., Milambo, M.J.P., Nkosi, S.F., Mukwada, G., Nyaga, M.M., and Tesfamichael, S.G. (2025). The Relationship Between Climate Change and Breast Cancer and Its Management and Preventative Implications in South Africa. Int. J. Environ. Res. Public Health, 22.","DOI":"10.3390\/ijerph22101486"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Fiore, M., Palella, M., Ferroni, E., Miligi, L., Portaluri, M., Marchese, C.A., Mensi, C., Civitelli, S., Tanturri, G., and Mangia, C. (2025). Air Pollution and Breast Cancer Risk: An Umbrella Review. Environments, 12.","DOI":"10.3390\/environments12050153"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/mc.22170","article-title":"Acute and chronic cadmium exposure promotes E-cadherin degradation in MCF7 breast cancer cells","volume":"54","author":"Ponce","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_184","first-page":"189","article-title":"The role of cadmium and nickel in estrogen receptor signaling and breast cancer: Metalloestrogens or not?","volume":"30","author":"Aquino","year":"2012","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"113579","DOI":"10.1016\/j.isci.2025.113579","article-title":"Multilevel classification framework for breast cancer cell selection and its integration with advanced disease models","volume":"28","author":"Dias","year":"2025","journal-title":"iScience"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Carvalho, E., Canberk, S., Schmitt, F., and Vale, N. (2025). Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies. Cancers, 17.","DOI":"10.3390\/cancers17071102"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490, 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Santos, I.P., Martins, C.B., Batista de Carvalho, L.A.E., Marques, M.P.M., and Batista de Carvalho, A.L.M. (2022). Who\u2019s Who? Discrimination of Human Breast Cancer Cell Lines by Raman and FTIR Microspectroscopy. Cancers, 14.","DOI":"10.3390\/cancers14020452"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-3-031-70875-6_21","article-title":"Clinical Implications of Breast Cancer Intrinsic Subtypes","volume":"1464","author":"Shan","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00292-022-01177-y","article-title":"Triple-negative breast cancer: Classification, current concepts, and therapy-related factors","volume":"44","author":"Sinn","year":"2023","journal-title":"Pathologie"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.21037\/tcr.2019.06.50","article-title":"Morphological and pathological features of basal-like breast cancer","volume":"8","author":"Botti","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ajpath.2017.03.016","article-title":"The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions","volume":"187","author":"Geyer","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1038\/npjbcancer.2016.36","article-title":"Triple-negative breast cancer: The importance of molecular and histologic subtyping, and recognition of low-grade variants","volume":"2","author":"Pareja","year":"2016","journal-title":"npj Breast Cancer"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Xiong, N., Wu, H., and Yu, Z. (2024). Advancements and challenges in triple-negative breast cancer: A comprehensive review of therapeutic and diagnostic strategies. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1405491"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Fan, Y., Wang, H., Zhang, H., Ma, T., and Zhao, Y. (2025). Integrating molecular targeting and immune modulation in triple-negative breast cancer: From mechanistic insights to therapeutic innovation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1711415"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Pont, M., Marques, M., and Sorolla, A. (2024). Latest Therapeutical Approaches for Triple-Negative Breast Cancer: From Preclinical to Clinical Research. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413518"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rvsc.2005.02.002","article-title":"Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues","volume":"79","author":"Millanta","year":"2005","journal-title":"Res. Vet. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/0300985818808531","article-title":"HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray-Fluorescence In Situ Hydridization-Based Study","volume":"56","author":"Muscatello","year":"2019","journal-title":"Vet. Pathol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"17314","DOI":"10.18632\/oncotarget.7551","article-title":"Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status","volume":"7","author":"Soares","year":"2016","journal-title":"Oncotarget"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1038\/s41598-022-20874-5","article-title":"Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways","volume":"12","author":"Taher","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Rida, P., Andreae, R., Bikhazi, N., Jackson, B., Wang, I., and Jinna, N. (2026). FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27041823"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e2308807120","DOI":"10.1073\/pnas.2308807120","article-title":"Triple-negative breast tumors are dependent on mutant p53 for growth and survival","volume":"120","author":"Dibra","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Munkacsy, G., Santarpia, L., and Gyorffy, B. (2023). Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086945"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"101043","DOI":"10.1016\/j.mcpro.2025.101043","article-title":"Proteomic Analysis of Hsp90beta-Selective Inhibitors Against Triple-Negative Breast Cancer to Gain a Mechanistic Insight","volume":"24","author":"Reynolds","year":"2025","journal-title":"Mol. Cell. Proteom."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"103834","DOI":"10.1016\/j.redox.2025.103834","article-title":"Oxidative stress-induced ZEB1 acetylation drives a hybrid epithelial-mesenchymal phenotype and promotes lung metastasis in triple-negative breast cancer","volume":"86","author":"Guo","year":"2025","journal-title":"Redox Biol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41523-025-00740-z","article-title":"Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets","volume":"11","author":"Felsheim","year":"2025","journal-title":"npj Breast Cancer"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Varzaru, V.B., Vlad, T., Popescu, R., Vlad, C.S., Moatar, A.E., and Cobec, I.M. (2024). Triple-Negative Breast Cancer: Molecular Particularities Still a Challenge. Diagnostics, 14.","DOI":"10.3390\/diagnostics14171875"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12282-023-01449-2","article-title":"Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients","volume":"30","author":"Nagahashi","year":"2023","journal-title":"Breast Cancer"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Asproni, P., Millanta, F., Ressel, L., Podesta, F., Parisi, F., Vannozzi, I., and Poli, A. (2021). An Immunohistochemical Study of the PTEN\/AKT Pathway Involvement in Canine and Feline Mammary Tumors. Animals, 11.","DOI":"10.3390\/ani11020365"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Zhou, Z., and Zhou, Q. (2025). Immunotherapy resistance in triple-negative breast cancer: Molecular mechanisms, tumor microenvironment, and therapeutic implications. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1630464"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"102140","DOI":"10.1016\/j.tranon.2024.102140","article-title":"The PIK3CA gene and its pivotal role in tumor tropism of triple-negative breast cancer","volume":"50","author":"Mallick","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"eadk1835","DOI":"10.1126\/sciadv.adk1835","article-title":"Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo","volume":"10","author":"Dibra","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.1038\/s41598-026-41375-9","article-title":"Serum programmed death ligand 2 is elevated in cats with mammary carcinoma","volume":"16","author":"Joao","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Franco, M., Seixas, F., Pires, M.D., Alves, A., Santos, A., Marrinhas, C., Vilhena, H., Santos, J., Fa\u00edsca, P., and Dias-Pereira, P. (2025). PD-1, PD-L1, and PD-L2 Expression as Predictive Markers in Rare Feline Mammary Tumors. Vet. Sci., 12.","DOI":"10.3390\/vetsci12080731"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: Research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Alkaabi, D., Arafat, K., Sulaiman, S., Al-Azawi, A.M., and Attoub, S. (2023). PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076420"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Dagher, E., Abadie, J., Loussouarn, D., Fanuel, D., Campone, M., and Nguyen, F. (2019). Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: A retrospective observational study. BMC Vet. Res., 15.","DOI":"10.1186\/s12917-018-1772-x"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Kedzierska, M., and Bankosz, M. (2024). Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy\u2014A Narrative Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13237131"},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Honma, N., Horii, R., Ito, Y., Saji, S., Younes, M., Iwase, T., and Akiyama, F. (2015). Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1686-y"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/vco.70033","article-title":"Tissue Proteomics of Feline Mammary Carcinoma: Differences in Protein Profiles Among Histological Grades Using Liquid Chromatography-Tandem Mass Spectrometry","volume":"24","author":"Aruvornlop","year":"2026","journal-title":"Vet. Comp. Oncol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"67686","DOI":"10.18632\/oncotarget.11891","article-title":"Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline\/taxane-based chemotherapy","volume":"7","author":"Denkert","year":"2016","journal-title":"Oncotarget"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.18632\/oncotarget.28071","article-title":"TP53 mutations determined by targeted NGS in breast cancer: A case-control study","volume":"12","author":"Andrikopoulou","year":"2021","journal-title":"Oncotarget"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15171\/ijb.1480","article-title":"Hspb1 and Tp53 Mutation and Expression Analysis in Cat Mammary Tumors","volume":"14","author":"Saif","year":"2016","journal-title":"Iran. J. Biotechnol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.tvjl.2012.10.021","article-title":"Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM\/p53 DNA damage pathway","volume":"196","author":"Pang","year":"2013","journal-title":"Vet. J."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/cas.12813","article-title":"Prognostic role of PIK3CA mutations of cell-free DNA in early-stage triple negative breast cancer","volume":"106","author":"Takeshita","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Miricescu, D., Totan, A., Stanescu, S., Badoiu, S.C., Stefani, C., and Greabu, M. (2020). PI3K\/AKT\/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010173"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Cossu-Rocca, P., Orru, S., Muroni, M.R., Sanges, F., Sotgiu, G., Ena, S., Pira, G., Murgia, L., Manca, A., and Uras, M.G. (2015). Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141763"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4143\/crt.2019.497","article-title":"PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy","volume":"52","author":"Guo","year":"2020","journal-title":"Cancer Res. Treat."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.18632\/oncotarget.2481","article-title":"Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences","volume":"5","author":"Kriegsmann","year":"2014","journal-title":"Oncotarget"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1245\/s10434-007-9751-7","article-title":"PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients","volume":"15","author":"Lai","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2010.12.016","article-title":"Activation of AKT in feline mammary carcinoma: A new prognostic factor for feline mammary tumours","volume":"191","author":"Maniscalco","year":"2012","journal-title":"Vet. J."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Prvanovic, M., Nedeljkovic, M., Tanic, N., Tomic, T., Terzic, T., Milovanovic, Z., Maksimovic, Z., and Tanic, N. (2021). Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer. Life, 11.","DOI":"10.3390\/life11111247"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1309\/AJCPR11DEAYPTUSL","article-title":"Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer","volume":"141","author":"Dean","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13046-023-02767-1","article-title":"FBXW7 in breast cancer: Mechanism of action and therapeutic potential","volume":"42","author":"Chen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"102703","DOI":"10.1016\/j.jbc.2022.102703","article-title":"The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage","volume":"298","author":"Richter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Sailo, B.L., Banik, K., Girisa, S., Bordoloi, D., Fan, L., Halim, C.E., Wang, H., Kumar, A.P., Zheng, D.L., and Mao, X.L. (2019). FBXW7 in Cancer: What Has Been Unraveled Thus Far?. Cancers, 11.","DOI":"10.3390\/cancers11020246"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00259-024-06704-y","article-title":"Targeting CXCR4\/CXCL12 axis via [(177)Lu]Lu-DOTAGA.(SA.FAPi)(2) with CXCR4 antagonist in triple-negative breast cancer","volume":"51","author":"Bao","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/cas.15293","article-title":"CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels","volume":"113","author":"Hayasaka","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Zielinska, K.A., and Katanaev, V.L. (2020). The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis. Cancers, 12.","DOI":"10.3390\/cancers12103071"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"105775","DOI":"10.18632\/oncotarget.22398","article-title":"Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes","volume":"8","author":"Marques","year":"2017","journal-title":"Oncotarget"},{"key":"ref_243","first-page":"1178223419898458","article-title":"Linkage Between Obesity Leptin and Breast Cancer","volume":"14","author":"Atoum","year":"2020","journal-title":"Breast Cancer"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"19189","DOI":"10.1038\/s41598-019-55674-x","article-title":"Modulation of the leptin receptors expression in breast cancer cell lines exposed to leptin and tamoxifen","volume":"9","author":"Linares","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4143\/crt.2006.38.3.126","article-title":"Effects of the expression of leptin and leptin receptor (OBR) on the prognosis of early-stage breast cancers","volume":"38","author":"Kim","year":"2006","journal-title":"Cancer Res. Treat."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Gameiro, A., Nascimento, C., Urbano, A.C., Correia, J., and Ferreira, F. (2021). Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.625147"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PAS.0000000000000949","article-title":"The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma","volume":"42","author":"Mills","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Nascimento, C., Urbano, A.C., Gameiro, A., Ferreira, J., Correia, J., and Ferreira, F. (2020). Serum PD-1\/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes. Cancers, 12.","DOI":"10.1101\/2020.04.25.061655"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Xu, A., Ayoub, S., Zhang, H., Wu, Y., Rau, M., and Ma, X. (2025). Regulatory T Cells in Invasive Breast Cancer: Prognosis, Mechanisms and Therapy. Cancers, 17.","DOI":"10.3390\/cancers17193172"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"0001","DOI":"10.47248\/chp2603010001","article-title":"The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer","volume":"3","author":"Das","year":"2025","journal-title":"Cancer Heterog. Plast."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21873\/invivo.13478","article-title":"Immunohistochemical Expression and Prognostic Value of COX-2 and Alpha-Smooth Muscle Actin-positive Cancer-associated Fibroblasts in Feline Mammary Cancer","volume":"38","author":"Guimaraes","year":"2024","journal-title":"In Vivo"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Nascimento, C., Gameiro, A., Correia, J., Ferreira, J., and Ferreira, F. (2022). The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications. Cells, 11.","DOI":"10.3390\/cells11162578"},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Rosen, S., Brisson, B.K., Durham, A.C., Munroe, C.M., McNeill, C.J., Stefanovski, D., Sorenmo, K.U., and Volk, S.W. (2020). Intratumoral collagen signatures predict clinical outcomes in feline mammary carcinoma. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236516"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1010428319901052","DOI":"10.1177\/1010428319901052","article-title":"Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer","volume":"42","author":"Dagher","year":"2020","journal-title":"Tumour Biol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41563-020-00849-5","article-title":"Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression","volume":"20","author":"Maller","year":"2021","journal-title":"Nat. Mater."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ijc.33009","article-title":"Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancer","volume":"147","author":"Zheng","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Singh, D.D., Yadav, D.K., and Shin, D. (2025). Targeting the CXCR4\/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer. Cells, 14.","DOI":"10.3390\/cells14181482"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"189144","DOI":"10.1016\/j.bbcan.2024.189144","article-title":"Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets","volume":"1879","author":"Vilela","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Pe, K.C.S., Saetung, R., Yodsurang, V., Chaotham, C., Suppipat, K., Chanvorachote, P., and Tawinwung, S. (2022). Triple-negative breast cancer influences a mixed M1\/M2 macrophage phenotype associated with tumor aggressiveness. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0273044"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.7150\/jca.44313","article-title":"Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment","volume":"11","author":"Madu","year":"2020","journal-title":"J. Cancer"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): A randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"CT262","DOI":"10.1158\/1538-7445.AM2025-CT262","article-title":"Efficacy and safety of the combination PKMYT1-inhibitor lunresertib and ATR-inhibitor camonsertib in patients with ovarian and endometrial cancers: Phase I MYTHIC study (NCT04855656) Free","volume":"85","author":"Schram","year":"2025","journal-title":"Cancer Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5326\/0420110","article-title":"Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases","volume":"42","author":"Novosad","year":"2006","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.2008.0244.x","article-title":"Evaluation of adjuvant doxorubicin-based chemotherapy for the treatment of feline mammary carcinoma","volume":"23","author":"McNeill","year":"2009","journal-title":"J. Vet. Intern. Med."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/vco.12660","article-title":"Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases","volume":"19","author":"Petrucci","year":"2021","journal-title":"Vet. Comp. Oncol."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Gameiro, A., Nascimento, C., Correia, J., and Ferreira, F. (2021). HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models. Cancers, 13.","DOI":"10.3390\/cancers13092007"},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Savan, N.A., Saavedra, P.V., Halim, A., Yuzbasiyan-Gurkan, V., Wang, P., Yoo, B., Kiupel, M., Sempere, L., Medarova, Z., and Moore, A. (2022). Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.959630"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1354\/vp.39-1-120","article-title":"MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis","volume":"39","author":"Millanta","year":"2002","journal-title":"Vet. Pathol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/13\/2136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:37:38Z","timestamp":1783053458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/13\/2136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":268,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cancers18132136"],"URL":"https:\/\/doi.org\/10.3390\/cancers18132136","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}